Delivery Order SPE2DB22D2211-SPE2DB25FSFZY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Viscoat syringes (0.5ml) valued at $27,117.66. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive pharmaceutical support vehicle running through December 2026. Performance will take place at the...
- The Defense Logistics Agency awarded a delivery order valued at $8,242.45 to AmerisourceBergen Drug Corp for the supply of Viscoat syringes (0.5mL) on June 26, 2025, with completion scheduled for June 27, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply fulfillment under AmerisourceBergen's...
- On September 18, 2025, the Defense Logistics Agency awarded a delivery order valued at $3,640.14 to AmerisourceBergen Drug Corp for the supply of Viscoat Syringe 0.5ML medical devices. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 19, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $4,853.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Viscoat syringes (0.5mL) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,426.76 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Viscoat syringes (0.5 mL). This is a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract requires completion by September 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $6,875.82 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Viscoat syringes (0.5 mL). This competitively awarded, firm fixed-price contract with an ultimate completion date of September 3, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $8,825.82 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Viscoat Syringes in 0.5ml quantities. The delivery order, which closes on July 24, 2025, represents a competitively awarded contract with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $14,627.79 delivery order to AmerisourceBergen Drug Corp for Viscoat syringes (0.5mL) on August 11, 2025, with a completion date of August 12, 2025. The contract employs firm fixed pricing and carries no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Viscoat syringes (0.75ML) under a firm fixed-price contract valued at $21,916.13. The order was competitively awarded without set-aside designation and is scheduled for completion by August 6, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,628.99 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Viscoat syringes (0.5mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 18, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFZYDelivery Order
The Defense Logistics Agency awarded a $31,007.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Viscoat syringes (0.5ML) on September 25, 2025, with completion expected by September 26, 2025. This non-set-aside contract represents a small-value transaction typical of the company's extensive pharmaceutical and medical supply portfolio. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products, medical devices, and healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen's established track record of competitively awarded federal contracts and its role as a critical vendor for Defense Health Agency and other government healthcare systems underscore its position as a major pharmaceutical distributor for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.0k | 9/25/25 |